| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
| 2006 | A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer | ONCOLOGY |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
| 2009 | A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor | ONCOLOGY |
| 2011 | Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma | ONCOLOGY |
| 2007 | Advanced Gastric Carcinoma with Signet Ring Cell Histology | ONCOLOGY |
| 2013 | Assessment of Adjuvant Trastuzumab-Associated Cardiac Toxicity in Korean Patients with Breast Cancer: A Single-Center Analysis | ONCOLOGY |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | ONCOLOGY |
| 2007 | ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer | ONCOLOGY |
| 2007 | Chemotherapy use and associated factors among cancer patients near the end of life | ONCOLOGY |
| 1999 | Chronological changes in incidences of polymorphic reticulosis in Korea and Japan | ONCOLOGY |
| 2015 | Clinical implications from a single-center study of colorectal adenocarcinoma in transplant recipients | ONCOLOGY |
| 2007 | Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases | ONCOLOGY |
| 2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
| 2011 | Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity | ONCOLOGY |
| 2012 | Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer | ONCOLOGY |
| 2020 | Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA | ONCOLOGY |
| 2011 | Controversies in surveillance and early diagnosis of hepatocellular carcinoma | ONCOLOGY |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2008 | Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas | ONCOLOGY |
| 2001 | Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer | ONCOLOGY |
| 2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | ONCOLOGY |
| 2008 | Epidemiology of hepatocellular carcinoma in Japan and Korea | ONCOLOGY |
| 2013 | FOXP3 Expression Is Related to High Ki-67 Index and Poor Prognosis in Lymph Node-Positive Breast Cancer Patients | ONCOLOGY |
| 2019 | HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells | ONCOLOGY |
| 2017 | Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection. | ONCOLOGY |
| 2009 | Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer | ONCOLOGY |
| 2008 | Magnetic resonance imaging of hepatocellular carcinoma using contrast media | ONCOLOGY |
| 2011 | Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer | ONCOLOGY |
| 2011 | Multidisciplinary management of nonresectable hepatocellular carcinoma | ONCOLOGY |
| 2014 | Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma. | ONCOLOGY |
| 2014 | Multimodality treatment with radiotherapy for huge hepatocellular carcinoma. | ONCOLOGY |
| 2010 | Outcome of adjuvant therapy for gallbladder cancer | ONCOLOGY |
| 1996 | Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain | ONCOLOGY |
| 2015 | Overexpression of reactive oxygen species scavenger enzymes is associated with a good prognosis in triple-negative breast cancer | ONCOLOGY |
| 1995 | Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gatric cancer | ONCOLOGY |
| 2009 | Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma | ONCOLOGY |
| 2007 | PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection | ONCOLOGY |
| 1998 | Plasmacytoma of the Gastrointestinal Tract in Korea: Higher Incidence than in Japan and Epstein-Barr Virus Association | ONCOLOGY |
| 2011 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | ONCOLOGY |
| 2010 | Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients | ONCOLOGY |
| 2015 | PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer | ONCOLOGY |
| 2011 | Radiotherapeutic strategies in the management of hepatocellular carcinoma | ONCOLOGY |
| 1997 | Relationship between p53 Overexpression and Gastric Cancer Progression | ONCOLOGY |
| 2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | ONCOLOGY |
| 2008 | Salvage chemotherapy with docetaxel and epirubicin for Advanced/Metastatic gastric cancer | ONCOLOGY |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2014 | Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study | ONCOLOGY |
| 2013 | Yttrium-90 radioembolization for hepatocellular carcinoma: What we know and what we need to know | ONCOLOGY |
